Tayla Cannon wasn't looking for investors when she showed up at that Austin event. The physiotherapist—Australian-trained, American-ambitious—had been building something quietly on the side while her Instagram following crept past 130,000. Athletic Rebuild, her online coaching business, was working. The content critiquing broken rehab models was resonating.
Then she met Megan Lightcap.
What followed was the kind of deal that sounds almost too neat: a $1.1 million seed round led by Slow Ventures' $60 million Creator Fund, announced November 18. No pitch deck drama, no months of cold emails. Just a conversation that turned into a check, because Lightcap's fund exists specifically to back creators who've already built something beyond the content itself.
Cannon's something is Rebuildr—software designed for independent rehab professionals trying to run practices that don't depend on insurance reimbursements or strip-mall clinic leases. Physical therapists, chiropractors, strength coaches. The clinicians stuck between outdated EMR systems built for big practices and fitness apps that can't legally touch protected health information.
The platform is live now. Both iOS and Android. HIPAA-compliant, or so it claims. Virtual assessments, program design with video libraries, async check-ins, Stripe payments. Pricing starts at $49 monthly for up to 10 clients—there's also a $499 mentorship add-on covering legal setup, business basics, marketing for practitioners who've never operated solo.
Whether it solves a real problem or just repackages existing tools with better branding remains to be seen.
The Creator Arbitrage Play
Slow Ventures' thesis here is straightforward, maybe even obvious: creators with real audiences can compress customer acquisition timelines. Why spend six figures on Facebook ads when you've already got 130,000 people who trust your clinical judgment enough to watch your Instagram reels?
The Creator Fund typically writes checks between $1 million and $3 million, often taking around 10 percent stakes in holding companies—with rights to invest in whatever the creator builds next. The LPs include institutional money: MIT, University of Michigan. Before Cannon, the fund's first public deal was $2 million into woodworking creator Jonathan Katz-Moses last August.
It's a bet that distribution matters more than it used to. Perhaps more than product-market fit itself, at least in the early innings.
Cannon had distribution. She'd spent two years putting what she calls "my brain on the internet"—rehab content, mobility drills, critiques of volume-based care models. Her background blends physiotherapy with a stint in interventional cardiology. She moved to the U.S. in 2023, which might explain some of the urgency around building tools for a market she was experiencing as an outsider.
Crowded Territory, Narrow Wedge
The competitive landscape here is... dense.
Trainerize, TrainHeroic, Everfit—they're all chasing trainers and coaches with similar workflow features. WebPT and Physitrack dominate the physical therapy clinic space with proper EMR infrastructure and patient engagement tools. Cannon's pitch is that she's unifying the remote-first rehab workflow for solo practitioners, adding mentorship for people who know how to treat shoulders but not how to structure an LLC.
Timing-wise, digital musculoskeletal care is having a moment. Hinge Health filed to go public late last year at valuations floating between $2.6 billion and $2.9 billion. Sword Health raised at a $3 billion valuation in 2024. But those companies target employers and health plans—the B2B market with its long sales cycles and enterprise contracts.
Rebuildr is aiming at the other side: individual clinicians building direct-to-consumer or cash-pay practices. Smaller checks, faster decisions, but also a fragmented market where customer lifetime value can get messy fast.
What Actually Gets Built Next
Cannon says the capital goes toward engineering hires, hardening security and compliance infrastructure, preparing for broader pilots in early 2026. According to TechCrunch's coverage—yes, they got there first—the platform is still in early rollout. Mentorship cohorts are forming. A clinician directory is in development.
The iOS app, listed under Cannon's developer account, was last updated November 6. Which is recent enough to suggest active work, but also raises questions about how much of this is fully baked versus aspirational.
The real test isn't whether Cannon can build software. Plenty of non-technical founders manage that with the right team. The test is whether independent rehab professionals—a group not exactly known for early SaaS adoption—will trust a platform built by someone they follow on Instagram enough to migrate their entire client management workflow.
And whether HIPAA compliance holds up under scrutiny when the stakes get real.
For now, it's a textbook creator-to-software story. One conversation in Austin, one check from a fund designed exactly for this scenario, one platform trying to wedge into a market that's simultaneously crowded and underserved.
The rest? That's just execution.
